{
    "clinical_study": {
        "@rank": "33305", 
        "arm_group": [
            {
                "arm_group_label": "Cohort A", 
                "arm_group_type": "Other", 
                "description": "S. aureus on at least 1 blood culture within 72 hours of beginning study drug"
            }, 
            {
                "arm_group_label": "Cohort B", 
                "arm_group_type": "Other", 
                "description": "MRSA on a baseline blood culture and on at least 1 additional blood culture after at least 72 hours of vancomycin and/or daptomycin treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a study of safety and efficacy of ceftaroline fosamil in Subjects with\n      Staphylococcus aureus Bacteremia or with Methicillin-Resistant Staphylococcus aureus (MRSA)\n      Bacteremia persisting after at least 72 hours of vancomycin and/or daptomycin treatment."
        }, 
        "brief_title": "Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Staphylococcus Aureus Bacteremia", 
            "Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteremia", 
                "Staphylococcal Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subjects with either S. aureus bacteremia or persistent MRSA bacteremia will be treated with\n      open label ceftaroline fosamil, safety will be monitored and clearance of bacteremia will be\n      evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Presence of bacteremia due solely to:\n\n               -  S. aureus on at least 1 blood culture within 72 hours of beginning study drug\n                  (Cohort A) OR\n\n               -  MRSA on a baseline blood culture and on at least 1 additional blood culture\n                  after at least 72 hours of vancomycin and/or daptomycin treatment (Cohort B).\n\n          2. Male or female \u2265 18 years of age.\n\n          3. If female of childbearing potential must be willing to practice sexual abstinence or\n             dual methods of contraception during treatment and for at least 30 days after the\n             last dose of study drug.\n\n          4. Expectation of survival for at least 2 months.\n\n        Exclusion Criteria:\n\n          1. For subjects in Cohort A: previous therapy for more than 48 hours with any parenteral\n             antibiotic with activity against S. aureus within 72 hours of positive blood culture\n             results.\n\n          2. For subjects in Cohort B: previous therapy for more than 48 hours with any parenteral\n             antibiotic with activity against MRSA, except vancomycin and/or daptomycin, within 72\n             hours of positive blood culture results confirming persistence.\n\n          3. Previous episode of S. aureus bacteremia within 3 months.\n\n          4. Known left-sided endocarditis or prosthetic heart valve.\n\n          5. Osteomyelitis or prosthetic joint infection except new onset nonhardware-associated\n             vertebral osteomyelitis.\n\n          6. History of any hypersensitivity or allergic reaction to any \u03b2-lactam antibacterial\n             agent.\n\n          7. Evidence of significant hepatic, hematologic, or immunologic impairment.\n\n          8. Pregnant or nursing females."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701219", 
            "org_study_id": "CPT-MD-32"
        }, 
        "intervention": {
            "arm_group_label": [
                "Cohort A", 
                "Cohort B"
            ], 
            "description": "Ceftaroline fosamil 600 mg intravenous (IV) infused over 60  (\u00b1 10) minutes every 8 hours (q8h) (\u00b1 1 hour) (dosing may be adjusted for renal function)", 
            "intervention_name": "Ceftaroline fosamil", 
            "intervention_type": "Drug", 
            "other_name": [
                "Teflaro\u00ae", 
                "PPI-0903", 
                "TAK-599", 
                "TAK599", 
                "PPI0903", 
                "Zinforo"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Methicillin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Staphylococcus aureus bacteremia", 
            "Methicillin-resistant Staphylococcus aureus bacteremia", 
            "MRSA bacteremia", 
            "Blood", 
            "Adult", 
            "Infections", 
            "Blood Culture"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "link": {
            "description": "Sponsor Website", 
            "url": "http://www.cerexa.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sylmar", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91342"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06102"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pensacola", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32504"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stuart", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34994"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30030"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Macon", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "31201"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Wayne", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46845"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02111"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grosse Pointe Woods", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48236"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Royal Oak", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48073"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Laconia", 
                        "country": "United States", 
                        "state": "New Hampshire", 
                        "zip": "03246"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Neptune", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07753"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07102"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jamaica", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11418"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43620"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29605"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Annandale", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22003"
                    }, 
                    "name": "Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roanoke", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "24014"
                    }, 
                    "name": "Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety evaluations will be conducted and assessments will include:\nAdverse events including deaths will be evaluated\nLaboratory: complete blood count (CBC) with differential and chemistry panel", 
            "measure": "Evaluate the safety of ceftaroline fosamil in adult Subjects (\u2265 18 years of age) with Staphylococcus aureus Bacteremia or with MRSA Bacteremia persisting after at least 72 hours of vancomycin and/or daptomycin treatment", 
            "safety_issue": "Yes", 
            "time_frame": "Between 3 and 119 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701219"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Efficacy outcome measures:\nTime to clearance of bacteremia\nTime to defervescence\nClinical outcome\nMortality\nReadmission", 
            "measure": "Evaluate the efficacy of ceftaroline fosamil in adult Subjects (\u2265 18 years of age) with Staphylococcus aureus Bacteremia or with MRSA Bacteremia persisting after at least 72 hours of vancomycin and/or daptomycin treatment", 
            "safety_issue": "No", 
            "time_frame": "60 days following completion of antibacterial therapy and discharge from the hospital, anticipated between 74 to 119 days"
        }, 
        "source": "Cerexa, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cerexa, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}